Post-Cesarean Surgical Scar Endometriosis: A Case Study and Clinical Insights from Somalia

case-report OA: gold CC-BY-NC-4.0
AI-generated summary by gemini-2.5-flash-lite, 2026-08-08

This case study reports a painful nodule at a cesarean scar confirmed as endometriosis, highlighting the need for clinicians to consider this rare condition in similar presentations.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by qwen3.7-flash, 2026-08-30 · read from full text

This case report describes a 30-year-old woman from Somalia presenting with cyclical pain and swelling at a cesarean section scar site, leading to a diagnosis of scar endometriosis. The patient underwent wide local excision of the mass, which was confirmed via histopathology to contain endometrial glands and stroma within fibrous tissue. Post-surgical follow-up indicated complete symptom resolution, reinforcing surgical excision as the primary effective treatment for this condition. This paper is centrally about endometriosis — specifically the rare extrapelvic manifestation known as cesarean scar endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

BACKGROUND: Scar endometriosis is a rare manifestation of extrapelvic endometriosis, characterized by the presence of endometrial tissue within a cesarean section scar. It typically manifests as cyclical pain and swelling at the site of the surgical incision and is often subject to misdiagnosis. CASE PRESENTATION: This report examines a case involving a 30-year-old Somali woman with a history of multiple childbirths, presenting with a painful nodule at the location of a previous lower segment cesarean section (LSCS) scar. Her symptoms were cyclical, worsening during menstruation. Ultrasonographic evaluation revealed an endometriotic lesion, and histological examination following surgical excision confirmed the diagnosis. The patient had an uneventful recovery post-surgery. CONCLUSION: It is important for clinicians to contemplate scar endometriosis in women presenting with a painful mass near a surgical scar that fluctuates with the menstrual cycle. Early identification and comprehensive surgical removal are crucial for effective management.
Full text 7,049 characters · extracted from pmc · 4 sections · click to expand

Case

A 30-year-old female patient from Somalia, with a medical history of five cesarean sections, presented to our gynecology clinic (Kaafi Hospital) with complaints of a one-year history of pain and swelling at the site of her cesarean section scar on the right lower abdominal wall. The pain exhibited a cyclical pattern, intensifying during her menstrual cycles. Her most recent cesarean section, conducted three years prior due to cephalopelvic disproportion, was followed by regular menstrual periods. The patient denied experiencing any systemic symptoms, such as fever, weight loss, or disturbances in gastrointestinal or urinary functions. Physical examination revealed a firm and tender mass, measuring 4×3.5 cm, situated at the right lateral edge of the Pfannenstial incision, without any changes to the skin or discharge. A pelvic examination showed no abnormalities. Ultrasound imaging identified a hypoechoic, solid lesion with limited vascularity within the subcutaneous layer, suggesting scar endometriosis. The patient underwent a wide local excision of the mass under spinal anesthesia; intraoperatively, the mass was well-circumscribed and adherent to the rectus sheath as depicted Figure 1 , and it was excised with clear margins. Histopathological analysis confirmed the presence of endometrial glands and stroma within fibrous tissue, consistent with endometriosis as mentioned Figure 2 . Figure 1 The image showing resected tissues. Figure 2 The image illustrates a histopathological slide of an excised specimen, revealing endometrial glands encircled by benign endometrial cells. The image showing resected tissues. The image illustrates a histopathological slide of an excised specimen, revealing endometrial glands encircled by benign endometrial cells. The patient was discharged on the second postoperative day and reported no symptoms at the 3-month follow-up.

Intro

Endometriosis is a condition characterized by the presence of functioning endometrial tissue outside the uterine cavity. While pelvic endometriosis is relatively common, its extrapelvic form, such as scar endometriosis, is both rare and frequently underdiagnosed. The incidence of cesarean scar endometriosis varies from 0.03% to 1.7% among women who have undergone a cesarean delivery. 1 Scar endometriosis is a condition that emerges due to the iatrogenic implantation of endometrial tissue into a surgical site during medical procedures such as cesarean sections, episiotomies, or laparotomies. Diagnosis is frequently delayed because of the low clinical suspicion among medical practitioners and the condition’s resemblance to other possible complications that can occur at surgical sites, such as hernias or granulomas. 2 Typical symptoms of scar endometriosis consist of cyclical pain and swelling, especially at the surgical scar site, with intensity and discomfort typically worsening during menstrual cycles. Diagnostic methods involve imaging techniques like ultrasound or MRI to detect endometriotic lesions, combined with histopathological analysis after surgical excision to confirm the diagnosis. 3 Management of this condition primarily involves the surgical removal of the affected tissue, ensuring that the excision margins are clear to effectively avert any potential recurrence. The prognosis for patients is generally positive following the surgical intervention, with most individuals achieving complete symptom resolution and not experiencing any subsequent recurrence. 4 An early diagnosis is critical to the success of the treatment, as it allows for prompt intervention and helps to prevent potential complications that could occur if the condition remains untreated.

Conclusion

This case highlights the crucial necessity for healthcare providers and clinicians to consider the potential presence of scar endometriosis in women who report cyclical pain specifically occurring at their cesarean incision sites. The elements of prompt and precise diagnosis, followed by timely surgical intervention, are vital for ensuring positive patient outcomes in such circumstances. It is particularly important for clinicians and healthcare professionals operating in resource-limited settings to maintain an elevated level of vigilance due to the possible limitations imposed on available diagnostic resources.

Discussion

Scar endometriosis is an uncommon but important consideration when evaluating masses at surgical incision sites. Its particular pathogenesis and associated risk factors demand careful diagnostic scrutiny. This condition arises from the inadvertent implantation of endometrial tissue during surgical procedures involving the uterus. This tissue later proliferates under hormonal influence. 5 Several factors highlight the need for heightened clinical awareness. Key risk contributors include cesarean deliveries, early hysterotomies, and inadequate postoperative site cleaning. This underscores the importance of meticulous surgical techniques and preventative measures. Clinical manifestations such as a palpable mass near a surgical scar, cyclic pain that worsens during menstruation, and a history of uterine surgeries strongly suggest scar endometriosis. These signs should trigger suspicion among healthcare providers. Diagnostic imaging tools like ultrasound and MRI play an essential role in preliminary evaluations. They offer visual evidence of endometriotic lesions, though they do not provide a definitive diagnosis. 6 Histopathological examination remains crucial for definitive confirmation of scar endometriosis. While fine-needle aspiration cytology (FNAC) can offer preliminary insights, it is less conclusive than histopathological analysis. Histopathology accurately identifies endometrial tissue presence in fibrous or scarred tissue, thereby verifying the condition. Surgical excision is the cornerstone approach for treatment. Thorough removal of the affected tissue with clear margins is recommended to minimize recurrence. This method is generally supported by positive outcomes, with patients achieving complete symptom resolution post-surgery. Some clinicians may propose medical therapies, such as GnRH agonists and oral contraceptives, especially for patients unsuitable for surgery. These treatments can offer temporary symptom relief by modulating hormonal influences on endometrial tissue. However, recurrence rates can be high when relying solely on medication. This underscores the superiority of surgical intervention for long-term effectiveness. 7 In summary, while alternative treatments exist, surgical excision remains the preferred and most effective strategy for managing scar endometriosis. The dual approach of accurate initial diagnosis through imaging and histopathological verification, followed by comprehensive surgical intervention, ensures both immediate and enduring patient relief. Nevertheless, ongoing discourse on medical therapies continues, especially for cases where surgery is not feasible. This highlights the need for tailored treatment plans based on individual patient circumstances.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: pmc

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-15T06:16:59.523076+00:00
pmc
last seen: 2026-05-13T20:22:03.195721+00:00
pubmed
last seen: 2026-09-15T06:11:59.380127+00:00
unpaywall
last seen: 2026-05-11T08:34:28.763810+00:00
License: CC-BY-NC-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine